| Hypoxia in prostate cancer: a powerful shield against tumour destruction? L Marignol, M Coffey, M Lawler, D Hollywood Cancer treatment reviews 34 (4), 313-327, 2008 | 155 | 2008 |
| MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma N Lynam-Lennon, JV Reynolds, L Marignol, OM Sheils, GP Pidgeon, ... Journal of molecular medicine 90, 1449-1458, 2012 | 127 | 2012 |
| DNA mismatch repair and the DNA damage response to ionizing radiation: making sense of apparently conflicting data LM Martin, B Marples, M Coffey, M Lawler, TH Lynch, D Hollywood, ... Cancer treatment reviews 36 (7), 518-527, 2010 | 111 | 2010 |
| NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer VA Belle, N McDermott, A Meunier, L Marignol Nature Reviews Urology 11 (9), 499-507, 2014 | 110 | 2014 |
| Topical management of acute radiation dermatitis in breast cancer patients: a systematic review and meta-analysis F Haruna, A Lipsett, L Marignol Anticancer research 37 (10), 5343-5353, 2017 | 107 | 2017 |
| Exposure to low dose ionising radiation: molecular and clinical consequences LM Martin, B Marples, TH Lynch, D Hollywood, L Marignol Cancer letters 338 (2), 209-218, 2013 | 105 | 2013 |
| Exposure to low dose ionising radiation: molecular and clinical consequences LM Martin, B Marples, TH Lynch, D Hollywood, L Marignol Cancer letters 338 (2), 209-218, 2013 | 105 | 2013 |
| Exposure to low dose ionising radiation: molecular and clinical consequences LM Martin, B Marples, TH Lynch, D Hollywood, L Marignol Cancer letters 338 (2), 209-218, 2013 | 105 | 2013 |
| Hypoxia, notch signalling, and prostate cancer L Marignol, K Rivera-Figueroa, T Lynch, D Hollywood Nature Reviews Urology 10 (7), 405-413, 2013 | 102 | 2013 |
| Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma N Lynam-Lennon, JV Reynolds, GP Pidgeon, J Lysaght, L Marignol, ... Radiation research 174 (6a), 703-711, 2010 | 90 | 2010 |
| Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer AS Perry, G O'Hurley, OA Raheem, K Brennan, S Wong, A O'Grady, ... International journal of cancer 132 (8), 1771-1780, 2013 | 60 | 2013 |
| The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers R Foley, L Marignol, AZ Thomas, IM Cullen, AS Perry, P Tewari, ... Cancer biology & therapy 8 (2), 118-124, 2009 | 55 | 2009 |
| Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells N McDermott, A Meunier, B Mooney, G Nortey, C Hernandez, S Hurley, ... Scientific reports 6 (1), 34796, 2016 | 51 | 2016 |
| MicroRNAs as putative mediators of treatment response in prostate cancer F O'kelly, L Marignol, A Meunier, TH Lynch, AS Perry, D Hollywood Nature Reviews Urology 9 (7), 397-407, 2012 | 51 | 2012 |
| Exposure to hypoxia following irradiation increases radioresistance in prostate cancer cells D Hennessey, LM Martin, A Atzberger, TH Lynch, D Hollywood, ... Urologic Oncology: Seminars and Original Investigations 31 (7), 1106-1116, 2013 | 47 | 2013 |
| Metformin and improved treatment outcomes in radiation therapy–A review NAB Samsuri, M Leech, L Marignol Cancer Treatment Reviews 55, 150-162, 2017 | 46 | 2017 |
| No evidence of XMRV in Irish prostate cancer patients with the R462Q mutation F D'arcy, R Foley, A Perry, L Marignol, M Lawler, E Gaffney, RGW Watson, ... European Urology Supplements 3 (7), 271, 2008 | 45 | 2008 |
| Potential of amifostine for chemoradiotherapy and radiotherapy-associated toxicity reduction in advanced NSCLC: a meta-analysis A Devine, L Marignol Anticancer Research 36 (1), 5-12, 2016 | 43 | 2016 |
| MGMT testing allows for personalised therapy in the temozolomide era A Dullea, L Marignol Tumor Biology 37, 87-96, 2016 | 40 | 2016 |
| Achieving hypoxia-inducible gene expression in tumours L Marignol, M Lawler, M Coffey, D Hollywood Cancer biology & therapy 4 (4), 365-370, 2005 | 40 | 2005 |
Lynn MartinPostdoctoral Scholar, Stanford UniversityAdresse e-mail validée de stanford.edu
